Discontinued Compound definition
Examples of Discontinued Compound in a sentence
If the other Party indicates it is not interested in initiating Development of such Discontinued Compound, the initiating Party may proceed with development of such Discontinued Compound as an Independent Lead Compound or an [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
MRE shall have the right of first refusal with respect to DTI's proposed grant to any bona fide third party of any right, title or interest of DTI in or to either any such composition, method or process or to any Non-Selected Compound or Discontinued Compound (a "Grant of DTI Rights").
If the other party indicates it is interested in participating in and committing resources to conduct Pre-Clinical Development of such Discontinued Compound, such Discontinued Compound shall be designated as a Designated Shared Compound as set forth in Section 3.2(a).
DTI agrees that MRE shall be entitled to recover the amount thereof from DTI first through offsets against license fees, milestones, royalties or other monies payable to DTI pursuant to this Agreement, and secondly through royalties on sales of the subject Non-Selected or Discontinued Compound and last, if the foregoing is insufficient, through a reasonable mechanism to be mutually agreed by the parties.
At any time after the date of termination or expiration of this Agreement, either party may, upon written notice to the other party, proceed with Pre-Clinical Development and Development of a Discontinued Compound as an Independent Compound or an Independent Product, and such party shall be deemed to be the Independent Party therefor, as provided in Section 3.15.
If the other party is CoCensys, and CoCensys indicates it is not interested in reinitiating Preclinical Development or Development or such Discontinued Compound, Warner shall proceed with Preclinical Development or Development of such Collaboration Lead Compound pursuant to the terms of this Agreement provided that CoCensys shall not be permitted to thereafter exercise the Re-engagement Option.
In the event Licensee in its sole and absolute discretion elects to pursue the development of a CT Compound and subsequently discontinues the development of that CT Compound (the "Discontinued Compound"), Licensee shall notify Licensor thereof in writing.
In addition to such recovery, MRE shall be entitled to seek injunctive relief enjoining the further manufacture and sale of the subject Non-Selected Compound or Discontinued Compound, without the need for MRE to post a bond or other security.
Within 120 days of Licensor's receipt of such notification from Licensee, if Licensor desires to re-acquire the rights to the Discontinued Compound, Licensor shall so notify Licensee thereof in writing, setting forth the terms and conditions upon which it is desires to re-acquire such rights, and Licensor and Licensee shall thereafter negotiate such terms and conditions in good faith.
Any Active Compound for which Astellas does not exercise its Development Option prior to the end of the applicable Development Option Period for such Active Compound (including Astellas’ termination of the Project in question pursuant to Section 12.2 (Termination)) will thereafter be a Discontinued Compound.